Biomarkers of Kidney Diseases

Biomarkers can be utilized clinically to screen for, analyze, or screen the activity of diseases and to manage molecularly focused on treatment or survey therapeutic response. Glomerular filtration rate (GFR) remains the perfect marker of kidney function. Unfortunately estimating GFR is tedious and in this manner GFR is typically evaluated from conditions that consider endogenous filtration markers like serum creatinine (SCr) and cystatin C (CysC). Distinctive biomarkers, for example, albuminuria may go before kidney work decay and have shown to have solid relationship with ailment movement and results. Consolidating creatinine, CysC and urine albumin to creatinine proportion improves chance stratification for kidney infection movement and mortality. Kidney damage atom and neutrophil gelatinase-related lipocalin are viewed as sensible biomarkers in urine and plasma to determine severity and prognosis of CKD.

  • Serum Creatinine
  • Cystatin
  • Urine Albumin

Related Conference of Biomarkers of Kidney Diseases

April 27-28, 2020

16th World Nephrology Conference

Singapore
June 10-11, 2020

21st Global Nephrologists Annual Meeting

Frankfurt, Germany
June 22-23, 2020

5th World Kidney Congress

Abu Dhabi, UAE
September 07-08, 2020

22nd World Nephrologists Summit

Tokyo, Japan
September 14-15, 2020

17th Asia Pacific Nephrology Conference

Osaka, Japan
September 16-17, 2020

15th Nephrology,Renal Medicine & Renal Care

Tokyo, Japan
October 12-13, 2020

24th European Nephrology Conference

Zurich, Switzerland
October 26-27, 2020

3rd International Conference on Nephrology

Dubai, UAE
November 09-10, 2020

International Conference on  Urology and Andrology

Bangkok, Thailand
November 23-24, 2020

World Congress and Expo on Nephrology

Hanoi, Vietnam

Biomarkers of Kidney Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in